Mounjaro®
Starting from £179.99/mo
Start journey Learn moreUsing your Wegovy pen for the first time can feel daunting, but the device is designed to be straightforward once you know what each step is actually doing. Wegovy (semaglutide) is a once-weekly subcutaneous injection — meaning a short, fine needle delivers the medicine just under the skin, not into a muscle. Before your first injection, the most useful decision you can make is whether you understand the process well enough to feel comfortable, or whether you want to talk it through with a clinician first. Our clinical team is available seven days a week for exactly that kind of conversation. Wegovy is a prescription-only medicine; a prescriber assesses your suitability before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Three sites work for Wegovy: the abdomen (belly), the front of the thigh, or the outer upper arm. All three are accessible and effective, though the upper arm is trickier to self-administer, most people find the abdomen the easiest starting point. Whichever you choose, vary the exact spot each week rather than repeatedly using the same patch of skin; this reduces the chance of irritation or lumpy tissue building up over time.
Timing matters more than most people expect. Pick a day of the week that suits your routine and stick to it. If you miss your usual day, it can be taken within five days; beyond that, skip to your next scheduled dose. For the exact missed-dose guidance, your Patient Information Leaflet is the definitive source, your prescriber can also advise. The Wegovy treatment overview covers what to expect across the full titration schedule.
One quick habit worth building before you start: hold the pen up to the light and check the liquid is clear and colourless. If it looks cloudy, discoloured or contains visible particles, do not use it. That check takes about ten seconds and catches a problem before it becomes one. The NHS semaglutide patient page has further guidance on what to look for.
Remove the pen from the fridge and let it sit at room temperature for around 30 minutes if you can, it makes the injection more comfortable. While you wait, wash your hands thoroughly. Clean the chosen skin site with an alcohol swab and let it dry completely; injecting through wet skin stings more than it needs to. Alcohol swabs designed for this purpose are available if you need a reliable supply.
Remove the pen cap. You do not need to prime Wegovy pens; they come ready to use. Press the pen firmly against the skin, you do not need to pinch the skin up unless your prescriber has advised you to. Activate the pen (press the button or unlock the mechanism, depending on the pen format you have been supplied), and hold it in place for the full count recommended in your leaflet. A click confirms the dose has been delivered; a window indicator on the pen will also change. Only remove the pen once the count is complete.
If you are using the 7.2mg single-dose pen approved by the MHRA in April 2026, the mechanism is slightly different from earlier formats, and our guide to how to use the Wegovy pen describes those differences specifically. For questions about pen formats or availability, the consultation is the right place to raise them, as specific dose supplies are confirmed clinically.
The used pen goes straight into a sharps container, not the household bin or recycling. A one-litre sharps bin is adequate for most people using a weekly pen. Your local council or GP practice can advise on collection; many pharmacies also accept sealed sharps containers.
Nausea is the most commonly reported side effect, particularly after starting or moving to a higher dose. It typically peaks in the first couple of days after an injection and fades. Eating smaller meals, avoiding very fatty or rich food around injection day, and staying well hydrated all help. If vomiting is prolonged or you cannot keep fluids down, contact your prescriber or GP rather than waiting it out.
More serious symptoms need prompt attention: severe stomach pain that reaches through to your back, signs of a serious allergic reaction (swelling of the face or throat, difficulty breathing), or sudden changes in vision. These are uncommon but warrant same-day medical help. The MHRA Yellow Card scheme allows you (or anyone) to report unexpected side effects directly, which helps build the wider safety picture for medicines like Wegovy.
The Patient Information Leaflet in your pack is the first place to look for anything dose- or device-specific. Beyond that, your prescriber is the right person to ask, not a forum, not a social post. If you are considering starting Wegovy and want to understand whether it is clinically appropriate for you, a free consultation with a GPhC-registered Independent Prescriber is the right first step. A real clinician reads your answers, not a piece of software.
For anyone wondering about injection-site questions in more depth (whether the upper arm is a realistic option for self-injection, for instance) we have covered that specifically on this page about upper-arm injections. And if a pen has failed to activate or feels stuck, troubleshooting a stuck Wegovy pen walks through the most common causes. If you would like to understand the broader landscape of weight-loss treatment options before committing to one, that is a reasonable place to start too.
Wegovy is a prescription-only medicine requiring clinical assessment. If you are ready to speak to our prescribers about whether it is right for you, start your free consultation, it takes a few minutes and is reviewed the same day. For a full walkthrough of the process, our pages on how to use Wegovy pens and how to use Wegovy cover each step in detail.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.